A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® Testing

The study is planned to observe and document the therapeutic decision-making process, treatment protocols, and clinical outcomes in patients with luminal breast cancer, whether they have undergone EndoPredict® testing or not

NCT Number	NCT07389408
Lead Sponsor	National and Kapodistrian University of Athens
Conditions	Breast Cancer, Breast Adenocarcinoma
Enrollment	2,000 participants
Start Date	2025-04-01
Primary Completion	2028-03-31 (estimated)
Study Completion	2038-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-05